查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765405

微流體設備系統的全球市場

Microfluidic Device Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 214 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球微流體設備系統市場規模將達 210 億美元

全球微流體設備系統市場規模預計在2024年為73億美元，預計2030年將達到210億美元，2024年至2030年的複合年成長率為19.3%。體外診斷是本報告分析的細分市場之一，預計其複合年成長率為19.3%，到分析期結束時規模將達到133億美元。製藥細分市場在分析期間內的複合年成長率預計為16.7%。

美國市場規模估計為 21 億美元，中國市場預計複合年成長率為 18.8%

美國微流體設備系統市場規模預計2024年達到21億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到33億美元，在2024-2030年的分析期間內，複合年成長率為18.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為16.9%和16.1%。在歐洲，預計德國市場的複合年成長率約為13.2%。

全球微流體設備系統市場—主要趨勢與促進因素摘要

什麼是微流體裝置系統？為什麼它們在現代生物醫學和工業應用中如此重要？

微流體裝置系統是一種微型平台，可透過晶片上蝕刻的通道操控少量流體（通常在微升或納升範圍內），從而實現對化學、生物和物理過程的精確控制。這些裝置整合了泵浦、閥門、感測器和攪拌機等組件，可實現診斷、藥物傳輸、化學分析和環境監測等各種應用。微流體具有處理速度更快、試劑消費量更少、成本更低和靈敏度更高的優勢，使其成為醫療保健、製藥、食品安全和研究等領域的重要技術。

微流體裝置系統的重要性在於其能夠快速、準確且經濟高效地對流體進行分析和合成，從而推動照護現場診斷、實驗室晶片技術和高通量篩檢的發展。透過微型化實驗室流程，微流體支援個人化醫療、高效的藥物研發和即時環境監測。隨著工業界追求更高的精度、更高的自動化程度和更永續的製程，微流體系統已成為現代生物醫學研究、臨床診斷和工業應用的重要工具。

技術進步如何影響微流體設備系統市場？

技術進步顯著提高了微流體裝置系統的精度、多功能性和整合能力，促進了各種應用領域的創新。其中一項重要進展是使用先進材料，例如聚二甲基矽氧烷 (PDMS)、玻璃和環烯烴共聚物 (COC)，這些材料具有更高的生物相容性、耐化學性和光學透明度。這些材料增強了微流體裝置的性能和可靠性，使其適用於複雜的分析、藥物傳輸系統和即時診斷。

自動化控制系統的整合進一步增強了微流體設備的功能。自動化平台整合了感測器、致動器和軟體，用於即時監測和操控流體流量、溫度和壓力。這種能力在數微流體等應用中至關重要，這些應用利用電訊號操控晶片上的微小液滴，從而實現快速精準的生化分析。自動化不僅提高了吞吐量和精度，還減少了人工干預，使微流體系統更具可擴展性，更能適應工業需求。

3D列印和微加工技術的進步拓展了微流體設備設計的可能性。 3D列印技術能夠快速原型製作複雜微流體結構的原型，支援針對診斷、藥物開發和環境測試等特定應用的客製化設備設計。軟光刻和微加工技術的創新提高了微流體晶片內部組件的微型化和整合度，從而推動了將多種分析功能整合微影術單一設備中的實驗室晶片設備的開發。這些創新不僅擴展了微流體系統的功能，也順應了生物醫學和工業流程微型化、自動化和精密化的大趨勢。

微流體裝置系統在各領域有哪些新的應用？

在對高精度、具成本效益和快速分析工具的需求推動下，微流體控元件系統正在各個領域中廣泛應用。在醫療保健領域，微流體廣泛應用於即時診斷，能夠快速檢測感染疾病、癌症和心血管疾病等疾病。實驗室晶片設備將樣本製備、反應和檢測整合在單一晶片上，用於血液檢測、血糖監測和基因分析，支援個人化醫療和疾病的早期檢測。微流體裝置也用於器官晶片模型，該模型模擬人體器官功能，用於測試藥物療效和疾病進展，從而減少對動物模型的依賴並加速藥物開發。

在製藥業，微流體在藥物研發中發揮著至關重要的作用。微流體能夠實現候選藥物的高通量篩檢、奈米藥物的高效合成以及藥物傳輸系統的可控性。微流體平台使研究人員能夠進行快速分析，在細胞層面上研究藥物交互作用，並創建複雜的製劑，例如脂質體和奈米顆粒，並精確控制其大小和成分。這些能力能夠提高藥物療效，減少副作用，並縮短開發時間，使微流體成為現代藥物研究的關鍵。

在環境領域，微流體設備用於即時監測水質、土壤分析和污染物檢測。它們能夠快速現場檢測重金屬、病原體和農藥等污染物，以支持環境保護和永續管理工作。在食品和飲料行業，微流體系統用於品管，以檢測食品中的病原體、過敏原和化學污染物。能夠提供快速且準確結果的微流體微流體是確保食品安全和符合監管標準的寶貴工具。微流體系統在這些領域的應用日益廣泛，凸顯了其在消費品和工業微流體提供準確、高效和擴充性的分析解決方案方面發揮的關鍵作用。

是什麼推動了微流體設備系統市場的成長？

微流體設備系統市場的成長受到多種因素的推動，包括快速診斷需求的不斷成長、精準醫療的進步以及藥物研發和環境監測應用的日益普及。全球範圍內對照護現場和分散式醫療保健解決方案的追求是主要成長要素之一。隨著醫療保健提供者尋求改善可及性、降低成本並更快地獲得結果，微流體系統提供了一種可擴展的解決方案，可在床邊、診所和遠端位置進行檢測。其體積小巧、週轉速度快且樣本需求量極低，使其成為快速疾病篩檢和監測的理想選擇。

個人化醫療日益受到重視，這進一步推動了對微流體設備系統的需求。精準醫療需要根據個人基因、環境和生活方式因素制定個人化治療方案，而微流體設備能夠有效處理基因和生物標記分析，從而支持個人化治療方案的選擇和監測。在腫瘤、感染疾病和代謝性疾病等領域，這種需求尤其強勁，因為個人化治療方法對於患者的預後至關重要。

藥物研發領域的進步也促進了微流體設備的普及。製藥公司正在利用微流體平台進行高通量篩檢、快速配製和候選藥物測試，從而縮短開發時間並降低成本。將混合、反應和檢測等多種功能整合到單一設備中，可以實現更有效率的工作流程，這使得微流體在藥物研究和生物製造領域越來越具有吸引力。

日益成長的環境監測需求以及日益嚴格的水、土壤和食品安全法規，推動了微流體設備在污染物和病原體快速檢測中的應用。其便攜性、準確性和低試劑消費量使其成為已開發市場和新興市場中即時監測的有效工具，可支援永續管理和​​合規性。

得益於材料、微型化和整合技術的持續創新，微流體設備系統市場可望實現強勁成長。這些趨勢，加上對快速、準確且經濟高效的分析解決方案日益成長的需求，使得微流體成為當代戰略的重要組成部分，這些戰略旨在改善醫療保健、加速藥物開發並支持各個領域的永續實踐。

部分

應用（POC測試、製藥和生命科學研究、藥物傳輸、分析設備、臨床和獸醫診斷、環境和工業）、工業（體外診斷、製藥、醫療設備）

受訪公司範例

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Dolomite Microfluidics
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microtechnologies BV
  • RainDance Technologies, Inc.
  • Roche Diagnostics（Schweiz）AG
  • Siemens Healthineers

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP16590

Global Microfluidic Device Systems Market to Reach US$21.0 Billion by 2030

The global market for Microfluidic Device Systems estimated at US$7.3 Billion in the year 2024, is expected to reach US$21.0 Billion by 2030, growing at a CAGR of 19.3% over the analysis period 2024-2030. In-vitro diagnostics, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$13.3 Billion by the end of the analysis period. Growth in the Pharmaceuticals segment is estimated at 16.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.8% CAGR

The Microfluidic Device Systems market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 18.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.9% and 16.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Microfluidic Device Systems Market - Key Trends & Drivers Summarized

What Are Microfluidic Device Systems, and Why Are They So Crucial in Modern Biomedical and Industrial Applications?

Microfluidic Device Systems are miniaturized platforms that manipulate small volumes of fluids (typically in the microliter or nanoliter range) through channels etched on a chip, enabling precise control of chemical, biological, and physical processes. These devices integrate components like pumps, valves, sensors, and mixers, allowing for various applications such as diagnostics, drug delivery, chemical analysis, and environmental monitoring. Microfluidics offers advantages like faster processing, reduced reagent consumption, lower costs, and improved sensitivity, making it a key technology in sectors like healthcare, pharmaceuticals, food safety, and research.

The importance of microfluidic device systems lies in their ability to provide rapid, accurate, and cost-effective analysis and synthesis of fluids, enabling advancements in point-of-care diagnostics, lab-on-a-chip technologies, and high-throughput screening. By miniaturizing laboratory processes, microfluidics supports personalized medicine, efficient drug discovery, and real-time environmental monitoring. As industries aim for higher precision, better automation, and more sustainable processes, microfluidic systems have become essential tools in modern biomedical research, clinical diagnostics, and industrial applications.

How Are Technological Advancements Shaping the Microfluidic Device Systems Market?

Technological advancements have significantly enhanced the precision, versatility, and integration capabilities of Microfluidic Device Systems, driving innovation across diverse applications. One of the major developments is the use of advanced materials, such as PDMS (polydimethylsiloxane), glass, and cyclic olefin copolymers (COCs), which offer improved biocompatibility, chemical resistance, and optical transparency. These materials enhance the performance and reliability of microfluidic devices, making them suitable for complex assays, drug delivery systems, and real-time diagnostics.

The integration of automated control systems has further improved the functionality of microfluidic devices. Automated platforms incorporate sensors, actuators, and software that enable real-time monitoring and manipulation of fluid flow, temperature, and pressure. This capability is crucial in applications like digital microfluidics, where electrical signals are used to manipulate tiny droplets on a chip, enabling rapid and precise biochemical assays. Automation not only increases throughput and accuracy but also reduces human intervention, making microfluidic systems more scalable and adaptable to industrial needs.

Advancements in 3D printing and microfabrication techniques have expanded the design possibilities of microfluidic devices. 3D printing allows for rapid prototyping of complex microfluidic structures, supporting customized device designs for specific applications in diagnostics, drug development, and environmental testing. Innovations in microfabrication, such as soft lithography and photolithography, have improved the miniaturization and integration of components within microfluidic chips, enabling the development of lab-on-a-chip devices that combine multiple analytical functions in a single device. These technological innovations not only expand the capabilities of microfluidic systems but also align with broader trends toward miniaturization, automation, and precision in biomedical and industrial processes.

What Are the Emerging Applications of Microfluidic Device Systems Across Different Sectors?

Microfluidic Device Systems are finding expanding applications across various sectors, driven by the need for high-precision, cost-effective, and rapid analytical tools. In the healthcare sector, microfluidics is widely used in point-of-care diagnostics, enabling rapid tests for conditions like infectious diseases, cancer, and cardiovascular disorders. Lab-on-a-chip devices, which integrate sample preparation, reaction, and detection on a single chip, are used for blood testing, glucose monitoring, and genetic analysis, supporting personalized medicine and early disease detection. Microfluidic devices are also used in organ-on-a-chip models, which simulate human organ functions to test drug effects and disease progression, reducing the reliance on animal models and accelerating drug development.

In the pharmaceutical industry, microfluidics plays a critical role in drug discovery and development. It enables high-throughput screening of drug candidates, efficient synthesis of nanomedicines, and controlled drug delivery systems. Microfluidic platforms allow researchers to perform rapid assays, study drug interactions at the cellular level, and create complex formulations like liposomes and nanoparticles with precise control over size and composition. These capabilities enhance drug efficacy, reduce side effects, and shorten development timelines, making microfluidics indispensable in modern drug research.

In the environmental sector, microfluidic devices are used for real-time monitoring of water quality, soil analysis, and detection of pollutants. They enable rapid, on-site testing for contaminants like heavy metals, pathogens, and pesticides, supporting efforts in environmental protection and sustainable management. In the food and beverage industry, microfluidic systems are employed for quality control, detecting pathogens, allergens, and chemical contaminants in food products. Their ability to provide quick and accurate results makes them valuable tools for ensuring food safety and compliance with regulatory standards. The expanding applications of microfluidic device systems across these sectors highlight their critical role in enabling precise, efficient, and scalable analytical solutions in both consumer and industrial settings.

What Drives Growth in the Microfluidic Device Systems Market?

The growth in the Microfluidic Device Systems market is driven by several factors, including increasing demand for rapid diagnostics, advancements in precision medicine, and rising adoption in drug discovery and environmental monitoring. One of the primary growth drivers is the global push for point-of-care diagnostics and decentralized healthcare solutions. As healthcare providers aim to improve access, reduce costs, and deliver faster results, microfluidic systems offer a scalable solution for performing tests at the bedside, in clinics, or in remote locations. Their small size, rapid turnaround, and minimal sample requirements make them ideal for quick disease screening and monitoring.

The growing emphasis on personalized medicine has further fueled demand for microfluidic device systems. As precision medicine requires tailored treatment plans based on individual genetic, environmental, and lifestyle factors, microfluidic devices enable efficient processing of genetic and biomarker analyses, supporting personalized therapy selection and monitoring. This demand is particularly strong in fields like oncology, infectious diseases, and metabolic disorders, where individualized treatment approaches are critical for patient outcomes.

Advancements in drug discovery and development have also contributed to the adoption of microfluidic devices. Pharmaceutical companies use microfluidic platforms for high-throughput screening, rapid formulation, and testing of drug candidates, reducing development time and costs. The ability to integrate multiple functions, such as mixing, reaction, and detection, in a single device supports more efficient workflows, increasing the appeal of microfluidics in drug research and biomanufacturing.

Rising environmental monitoring needs and stricter regulations for water, soil, and food safety have driven the use of microfluidic devices for rapid detection of contaminants and pathogens. Their portability, accuracy, and low reagent consumption make them effective tools for real-time monitoring in both developed and emerging markets, supporting sustainable management and regulatory compliance.

With ongoing innovations in materials, miniaturization, and integration technologies, the microfluidic device systems market is poised for robust growth. These trends, combined with increasing demand for rapid, accurate, and cost-effective analytical solutions, make microfluidics a vital component of modern strategies focused on improving healthcare, accelerating drug development, and supporting sustainable practices across various sectors.

SCOPE OF STUDY:

The report analyzes the Microfluidic Device Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Point of Care Testing, Pharmaceutical and Life Science Research, Drug Delivery, Analytical Devices, Clinical and Veterinary Diagnostics, Environment and Industrial); Industry (In-vitro Diagnostics, Pharmaceuticals, Medical Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 23 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Dolomite Microfluidics
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microtechnologies B.V.
  • RainDance Technologies, Inc.
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Microfluidic Device Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Point-of-Care Diagnostics Drives Microfluidic Device Adoption
    • Advancements in Lab-on-a-Chip Technology Propel Market Growth
    • Increasing Use in Drug Discovery Expands Microfluidics Market Opportunities
    • Miniaturization of Medical Devices Strengthens Business Case for Microfluidics
    • Expanding Use in Genomics and Proteomics Sets the Stage for Growth
    • Strong Demand for Rapid Testing During Disease Outbreaks Generates Demand
    • Use in Cell Analysis and Manipulation Expands Addressable Market
    • Growing Focus on Organ-on-Chip Technology Drives Microfluidics Adoption
    • Expanding Applications in Food Safety Testing Spur Microfluidic Adoption
    • Growing Use in Environmental Monitoring Generates Demand for Devices
    • Rising Focus on Microfluidics in Biopharmaceutical Production Sustains Growth
    • Increasing Demand for Home Healthcare Devices Sets the Stage for Microfluidics Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microfluidic Device Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for In-vitro diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Point of care testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pharmaceutical and life science research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Drug delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Analytical devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical and veterinary diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Environment and Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • JAPAN
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • CHINA
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • EUROPE
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • FRANCE
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • GERMANY
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030

IV. COMPETITION